Sungkeun Kang

Dr. Sungkeun Kang

orcid

Research Focus & Metrics

Representative Publications

View All Publications
1 January 2026 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
JKJin Kyong Kim
Jin Kyong Kim
DKDong Wook Kim
Dong Wook Kim
JRJae Sang Ryu
Jae Sang Ryu
SKSungkeun Kang
Sungkeun Kang
EKEUN JIN KIM
EUN JIN KIM
WCWoong Youn Chung
Woong Youn Chung
Kim JK, et al. Ann Surg Treat Res. 2026 Jan;110(1):3-11. https://doi.org/10.4174/astr.2026.110.1.3

13 November 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
SKSungkeun Kang
Sungkeun Kang
HCHojin Cho
Hojin Cho
EKEunjin Kim
Eunjin Kim
JKJin Kyong Kim
Jin Kyong Kim
SKSang-Wook Kang
Sang-Wook Kang
WCWoungyoun Chung
Woungyoun Chung
Introduction: Accurate localization of hyperactive parathyroid glands is essential in managing primary hyperparathyroidism. Despite advances in imaging, discordant findings still complicate surgical planning. Tc-99m-sestaMIBI SPECT/CT (MIBI SPECT/CT) and 18 F-Choline PET/CT (FCH PET/CT) are commonly used, particularly when localization is discordant. Objective: This study compared the findings of FCH PET/CT and MIBI SPECT/CT with intraoperative outcomes in patients who underwent parathyroidectomy for primary hyperparathyroidism. In discordant cases, the relative diagnostic performance and postoperative outcomes of the two modalities were analyzed. Materials and methods: We retrospectively reviewed 133 patients who underwent parathyroidectomy between January 2020 and December 2024 and had both MIBI SPECT/CT and FCH PET/CT. Patients were classified according to concordance between imaging and surgical localization: Group 1 (both modalities concordant), Group 2 (MIBI concordant only), Group 3 (FCH concordant only), and Group 4 (both discordant). Diagnostic performance (sensitivity and PPV) and biochemical cure—defined as normalization of parathyroid hormone (PTH) and calcium at 6 and 12 months—were compared between Groups 2 and 3. Results: Of 133 patients, 82 (61.7%) were in Group 1, 5 (3.8%) in Group 2, 37 (27.8%) in Group 3, and 9 (6.8%) in Group 4. Sensitivity and PPV were 74.4% and 86.1% for MIBI, and 97.5% and 91.5% for FCH PET/CT, respectively. The biochemical cure rate was 80.0% vs 94.6% at 6 months and 50.0% vs 87.5% at 12 months for Groups 2 and 3, with calcium levels remaining within the normal range. Preoperative PTH levels and chief-cell proportions were higher in Group 3 (91.9%) than in Group 1 (82.6%). Discussion: FCH PET/CT demonstrated better diagnostic performance and higher cure rates than MIBI SPECT/CT in discordant cases. Although differences were not statistically significant, they may be influenced by preoperative parathyroid activity and histologic composition. Conclusion: FCH PET/CT showed a trend toward improved diagnostic performance and postoperative cure compared with MIBI SPECT/CT in discordant cases. While not superior in all situations, it can complement MIBI SPECT/CT and enhance surgical decision-making in complex clinical settings.

11 November 2026 in Cancers
Verified
Journal Article
Open access
PDF file
SKSungkeun Kang
Sungkeun Kang
DKDong Wook Kim
Dong Wook Kim
JRJae Sang Ryu
Jae Sang Ryu
SLSuk Won Lee
Suk Won Lee
EKEUN JIN KIM
EUN JIN KIM
WCWoong Youn Chung
Woong Youn Chung
Background/Objectives: The da Vinci SP system offers a single-port configuration with flexible, multijointed instruments, but evidence comparing it with the Xi system in robotic bilateral total thyroidectomy (BTT) remains limited. This study compared surgical outcomes and postoperative complications between the two platforms. Methods: We retrospectively reviewed 548 consecutive patients with thyroid cancer who underwent robotic BTT by a single surgeon between 2010 and 2024. Patients were analyzed separately according to central compartment neck dissection (CCND) or modified radical neck dissection (MRND). Propensity score matching was performed at a 1:1 ratio based on age, sex, body mass index, and tumor size. Serial calcium and parathyroid hormone (PTH) levels were additionally examined in matched patients who developed transient hypocalcemia. Results: The overall cohort included 396 patients in the Xi group and 152 in the SP group. Overall complications (34.3% vs. 21.7%, p = 0.003) and transient hypocalcemia (28.3% vs. 14.5%, p = 0.001) were less frequent in the SP group. Propensity score matching yielded 70 pairs in the CCND cohort and 47 pairs in the MRND cohort. In the matched CCND cohort, the SP group had lower rates of overall complications (18.6% vs. 40.0%, p = 0.024) and transient hypocalcemia (10.0% vs. 30.0%, p = 0.013). Complication rates did not differ significantly between the platforms in the matched MRND cohort. Surgical and pathological outcomes were generally comparable. Among patients with transient hypocalcemia, the decline in calcium at 6 months was smaller in the SP group in the CCND cohort (p = 0.013), whereas the MRND cohort showed smaller declines in PTH at selected postoperative time points but no significant between-group differences in calcium changes. Conclusion: Robotic BTT using the da Vinci SP system and the Double Bipolar Method was safe and feasible. Compared with the Xi system, this approach achieved generally comparable surgical and pathological outcomes and was associated with fewer postoperative complications in the matched CCND cohort.